Work

Human vaccines and immunotherapeutics: News February 2025

Year: 2025

Type: editorial

Abstract: The IL-12-containing antibody–drug conjugate PDS01ADC (PDS Biotech) combined with standard-of-care PDL1 inhibitor induced an objective-response rate (ORR) of 37% in 50 patients with recurrent or me...

Source: Human Vaccines & Immunotherapeutics

DOI: 10.1080/21645515.2025.2482479

Authors: Ronald Ellis, Adam Weiss

Institution: Taylor and Francis (United Kingdom)

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $3,175

OpenAlex ID: W4408870605

Cites: 2

Cited by: 2

Related to: 10